SFFS
Stonehage Fleming Financial Services Portfolio holdings
AUM
$3.44B
This Quarter Return
+10.58%
1 Year Return
+25.04%
3 Year Return
+85.31%
5 Year Return
+118.37%
10 Year Return
+385.45%
AUM
$2.74B
AUM Growth
+$2.74B
(+75%)
Cap. Flow
+$1.03B
Cap. Flow
% of AUM
37.47%
Top 10 Holdings %
Top 10 Hldgs %
55.73%
Holding
243
New
67
Increased
18
Reduced
51
Closed
44
Top Buys
| 1 |
Microsoft
MSFT
|
$239M |
| 2 |
McDonald's
MCD
|
$118M |
| 3 |
Edwards Lifesciences
EW
|
$114M |
| 4 |
Thermo Fisher Scientific
TMO
|
$113M |
| 5 |
Stryker
SYK
|
$108M |
Top Sells
| 1 |
Walt Disney
DIS
|
$37.1M |
| 2 |
NVIDIA
NVDA
|
$13.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$5.83M |
| 4 |
Zoetis
ZTS
|
$5.06M |
| 5 |
Visa
V
|
$4.57M |
Sector Composition
| 1 | Technology | 24.03% |
| 2 | Healthcare | 23.18% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Financials | 12.21% |
| 5 | Communication Services | 11.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Futu Holdings
FUTU
$27B
| – | – |
-60
| Closed | -$3.11K |
|
227
East-West Bancorp
EWBC
$14.7B
| – | – |
-7,225
| Closed | -$401K |
|
228
Dow Inc
DOW
$17B
| – | – |
-693
| Closed | -$38K |
|
229
DuPont de Nemours
DD
$31.6B
| – | – |
-693
| Closed | -$49.7K |
|
230
Cisco
CSCO
$268B
| – | – |
-3,510
| Closed | -$183K |
|
231
Comcast
CMCSA
$125B
| – | – |
-1,230
| Closed | -$46.6K |
|
232
Cigna
CI
$80.2B
| – | – |
-202
| Closed | -$51.6K |
|
|
CHX
233
DELISTED
ChampionX
CHX
| – | – |
-4,755
| Closed | -$125K |
|
234
CDW
CDW
$21.4B
| – | – |
-4,125
| Closed | -$804K |
|
235
CAE Inc
CAE
$8.55B
| – | – |
-1,239
| Closed | -$28K |
|
236
Citigroup
C
$175B
| – | – |
-5,343
| Closed | -$251K |
|
237
Bristol-Myers Squibb
BMY
$96.7B
| – | – |
-195
| Closed | -$13.5K |
|
238
Brown-Forman Class B
BF.B
$13.3B
| – | – |
-2,086
| Closed | -$134K |
|
239
KE Holdings
BEKE
$21.8B
| – | – |
-92,500
| Closed | -$1.74M |
|
240
BCE
BCE
$22.9B
| – | – |
-785
| Closed | -$35.1K |
|
241
Alerian MLP ETF
AMLP
$10.6B
| – | – |
-1,500
| Closed | -$58K |
|
242
AbbVie
ABBV
$374B
| – | – |
-1,740
| Closed | -$277K |
|
243
OR Royalties Inc.
OR
$6.27B
| – | – |
-2,000
| Closed | -$31.6K |
|